This review offers a framework for Medicaid programs to broadly assess cell and gene therapies, evaluate payment options, and ensure equitable access. Share: Previous Post Systemic Corticosteroids to Prevent Bronchopulmonary Dysplasia Next Post JAMA Pediatrics Related Articles Clinical Practice Guidelines Genomic Models to Predict Outcomes in Autistic Children Clinical Practice Guidelines Developmental Timing of Associations Among Parenting, Brain Architecture, and Mental Health Clinical Practice Guidelines BMI and Associated Medical Expenditures in the US Among Privately Insured Individuals Aged 2 to 19 Years in 2018 Clinical Practice Guidelines Cost-effectiveness and ROI of a Case-Finding Program for Familial Hypercholesterolemia in Children in the Netherlands Clinical Practice Guidelines On Masks and Emotion Recognition Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment Name * Email * Website Save my name, email, and website in this browser for the next time I comment.